Research Extras

View a video of infectious disease expert Keith Klugman, MD, PhD, and his new Gates Foundation-funded project to map the DNA of 20,000 pneumonia-causing strains.

Find out about the awards from Emory's seventh annual Celebration of Technology and Innovation.

Read a column by Emory Federal Affairs Director Cameron Taylor and watch a video of Raymond Dingledine discussing the impact of sequestration on research.

Learn about cardiologist Leslee Shaw and the Red Dress Award honoring her contributions to the fight against heart disease among women.

Read an Emory Magazine article about William Foege, presidential distinguished professor emeritus of international health at Rollins School of Public Health, and his work to eradicate smallpox, chronicled in his book House on Fire.

Pursuing Promising New Approaches to an HIV Vaccine
New ways of looking at the stealthy pathways used by HIV are guiding Emory Vaccine Center scientists in their quest to develop an effective vaccine. Creative new approaches range from triggering the correct immune responses very early in the infection to creating a nanoparticle vaccine that could produce broadly neutralizing antibodies. Read more...

Cooling Treatment for Ischemic Strokes Shows Promise
In an early-stage clinical trial called ReCCLAIM I, researchers induced hypothermia to try and halt or slow the loss of brain cells in patients who had a stroke and had the blockage to their brain arteries removed. The study's aim was to determine safety of the procedure, but based on the promising results, researchers plan to conduct a larger, randomized clinical trial. Read more..

H1N1 Vaccination Led to Fewer Premature Births, Healthier Babies
Pregnant women who received the H1N1 influenza vaccine during the 2009 pandemic were less likely to have premature babies, and their babies weighed more on average. Influenza infections during pregnancy have been associated with adverse infant outcomes such as preterm birth. Read more...

New Drug Could Limit Ongoing Damage Following Seizures
New research in mice could lead to a better treatment to prevent brain injury after prolonged epileptic seizures. Status epilepticus, a persistent seizure lasting longer than 30 minutes, leads to around 55,000 deaths each year in the U.S. It can be caused by stroke, brain tumor, infection, or epilepsy. Current treatment is an anticonvulsant or general anesthesia, but a new drug could prevent ongoing brain damage. Read more...

Canine Study Tests New Treatment for Brain Tumors
Emory and the University of Georgia School of Veterinary Medicine are testing a nanoparticle-based experimental drug to treat dogs following surgery for naturally occurring brain tumors. The research goal is to translate successful treatments in dogs into therapy for humans with similar malignant brain tumors called glioblastomas. Read more...